English

ZYMOGENETICS INC

EDGAR

Annual report amendment (10-K/A) · filed 2010-08-24

37 filing records in this dataset, filed from 2002-03-28 to 2010-08-24. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

37.7 million USD

2010-06-30 · USD

Exact inputs and evidence

Revenue: 37711000 USD Source

Operating margin

-3.27%

2010-06-30 · %

Exact inputs and evidence

Operating Income: -1232000 USD Source
Revenue: 37711000 USD Source

Operating cash flow

-24.5 million USD

2010-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -61593000 USD Source
Operating Cash Flow: -37114000 USD Source

Free cash flow

-24.6 million USD

2010-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -61593000 USD Source
Operating Cash Flow: -37114000 USD Source
Capital Expenditure: 196000 USD Source
Capital Expenditure: 33000 USD Source

Cash and cash equivalents: 24 million USD 2010-06-30 Source
Exact value

24007000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

163 million USD

2009-07-01 – 2010-06-30

Exact inputs and evidence

Revenue: 27456000 USD · 2009-07-01 – 2009-09-30 Source
Revenue: 136972000 USD · 2009-01-01 – 2009-12-31 Source
Revenue: 74873000 USD · 2009-01-01 – 2009-09-30 Source
Revenue: 35515000 USD · 2010-01-01 – 2010-03-31 Source
Revenue: 37711000 USD · 2010-04-01 – 2010-06-30 Source

Net income

-4.07 million USD

2009-07-01 – 2010-06-30

Exact inputs and evidence

Net income: -11444000 USD · 2009-07-01 – 2009-09-30 Source
Net income: -42981000 USD · 2009-01-01 – 2009-12-31 Source
Net income: -56550000 USD · 2009-01-01 – 2009-09-30 Source
Net income: -2438000 USD · 2010-01-01 – 2010-03-31 Source
Net income: -3752000 USD · 2010-04-01 – 2010-06-30 Source

Operating cash flow

-5.56 million USD

2009-07-01 – 2010-06-30

Exact inputs and evidence

Operating cash flow: 13963000 USD · 2009-01-01 – 2009-09-30 Source
Operating cash flow: 29451000 USD · 2009-01-01 – 2009-06-30 Source
Operating cash flow: 85488000 USD · 2009-01-01 – 2009-12-31 Source
Operating cash flow: 13963000 USD · 2009-01-01 – 2009-09-30 Source
Operating cash flow: -37114000 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: -61593000 USD · 2010-01-01 – 2010-06-30 Source
Operating cash flow: -37114000 USD · 2010-01-01 – 2010-03-31 Source

Capital expenditure

1.04 million USD

2009-07-01 – 2010-06-30

Exact inputs and evidence

Capital expenditure: 1306000 USD · 2009-01-01 – 2009-09-30 Source
Capital expenditure: 955000 USD · 2009-01-01 – 2009-06-30 Source
Capital expenditure: 1801000 USD · 2009-01-01 – 2009-12-31 Source
Capital expenditure: 1306000 USD · 2009-01-01 – 2009-09-30 Source
Capital expenditure: 33000 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 196000 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 33000 USD · 2010-01-01 – 2010-03-31 Source

Free cash flow

-6.6 million USD

2009-07-01 – 2010-06-30

Exact inputs and evidence

Operating cash flow: 13963000 USD · 2009-01-01 – 2009-09-30 Source
Operating cash flow: 29451000 USD · 2009-01-01 – 2009-06-30 Source
Operating cash flow: 85488000 USD · 2009-01-01 – 2009-12-31 Source
Operating cash flow: 13963000 USD · 2009-01-01 – 2009-09-30 Source
Operating cash flow: -37114000 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: -61593000 USD · 2010-01-01 – 2010-06-30 Source
Operating cash flow: -37114000 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 1306000 USD · 2009-01-01 – 2009-09-30 Source
Capital expenditure: 955000 USD · 2009-01-01 – 2009-06-30 Source
Capital expenditure: 1801000 USD · 2009-01-01 – 2009-12-31 Source
Capital expenditure: 1306000 USD · 2009-01-01 – 2009-09-30 Source
Capital expenditure: 33000 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 196000 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 33000 USD · 2010-01-01 – 2010-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2010-08-24.

Financial data available through: 2009-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2009-12-31
Operating income: 11 of 11 periods available· newest 2009-12-31
Net income: 11 of 11 periods available· newest 2009-12-31
Operating cash flow: 11 of 11 periods available· newest 2009-12-31
Capital expenditure: 11 of 11 periods available· newest 2009-12-31
Total assets: 10 of 11 periods available· newest 2009-12-31
Total liabilities: 2 of 11 periods available· newest 2001-12-31
Current assets: 10 of 11 periods available· newest 2009-12-31
Current liabilities: 10 of 11 periods available· newest 2009-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2009-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+85.1%

Prior period

USD 73.99 million

2008-01-01 – 2008-12-31
Current period

USD 136.97 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

136972000 − 73989000 = 62983000 USD

73989000 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
136972000 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ZYMOGENETICS INC · 2009-12-31 ZYMOGENETICS INC (edgar:1129425) Year-over-year change in Revenue: 62983000 USD Concept: fundies:Revenue Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 136972000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#5127 Input fundies:Revenue: 73989000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#5127
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 73.26 million

Prior period

−USD 116.24 million

2008-01-01 – 2008-12-31
Current period

−USD 42.98 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

-42981000 − -116241000 = 73260000 USD

-116241000 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
-42981000 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ZYMOGENETICS INC · 2009-12-31 ZYMOGENETICS INC (edgar:1129425) Year-over-year change in Net income: 73260000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -42981000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6300 Input fundies:NetIncome: -116241000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6300
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 195.13 million

Prior period

−USD 109.65 million

2008-01-01 – 2008-12-31
Current period

USD 85.49 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

85488000 − -109645000 = 195133000 USD

-109645000 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
85488000 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ZYMOGENETICS INC · 2009-12-31 ZYMOGENETICS INC (edgar:1129425) Year-over-year change in Operating cash flow: 195133000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 85488000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6608 Input fundies:OperatingCashFlow: -109645000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6608
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-62.5%

Prior period

USD 4.8 million

2008-01-01 – 2008-12-31
Current period

USD 1.8 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

1801000 − 4802000 = -3001000 USD

4802000 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
1801000 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ZYMOGENETICS INC · 2009-12-31 ZYMOGENETICS INC (edgar:1129425) Year-over-year change in Capital expenditure: -3001000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1801000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6650 Input fundies:CapitalExpenditure: 4802000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6650
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2009 2009-01-01 – 2009-12-31

Revenue USD 136.97 million 100% of revenue
Cost of revenue USD 7.63 million 5.6% of revenue
Operating expenses USD 161.4 million 118% of revenue
Operating income −USD 32.06 million −23% of revenue
Tax, interest and other Derived USD 10.93 million 8% of revenue
Net income −USD 42.98 million −31% of revenue

Cash

Operating cash flow USD 85.49 million 62% of revenue
Capital expenditure USD 1.8 million 1.3% of revenue
Free cash flow Derived USD 83.69 million 61% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2000 Operating loss: operating costs were 189% of revenue.
2001 Operating loss: operating costs were 348% of revenue.
2002 Operating loss: operating costs were 169% of revenue.
2003 Operating loss: operating costs were 333% of revenue.
2004 Operating loss: operating costs were 343% of revenue.
2005 Operating loss: operating costs were 287% of revenue.
2006 Operating loss: operating costs were 637% of revenue.
2007 Operating loss: operating costs were 492% of revenue.
2008 Operating loss: operating costs were 260% of revenue.
2009 Operating loss: operating costs were 123% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2000 2000-01-01 – 2000-12-31	32464247	61405874 Derived	-28941627	1435433 Derived	-30377060	-43607485 Derived	Source 2000-01-01 – 2000-12-31: 32464247 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -28941627 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -30377060 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -37990447 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 5617038 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	17828000	62034000 Derived	-44206000	-7327000 Derived	-36879000	-27121000 Derived	Source 2001-01-01 – 2001-12-31: 17828000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -44206000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -36879000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -18940000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 8181000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	52775000	89381000 Derived	-36606000	-6263000 Derived	-30343000	-21320000 Derived	Source 2002-01-01 – 2002-12-31: 52775000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -36606000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -30343000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -11377000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 9943000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	25957000	86361000 Derived	-60404000	-833000 Derived	-59571000	-62356000 Derived	Source 2003-01-01 – 2003-12-31: 25957000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -60404000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -59571000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -49794000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 12562000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	35694000	122589000 Derived	-86895000	1861000 Derived	-88756000	-48920000 Derived	Source 2004-01-01 – 2004-12-31: 35694000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -86895000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -88756000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -31951000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 16969000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	42909000	122936000 Derived	-80027000	-2000000 Derived	-78027000	-87303000 Derived	Source 2005-01-01 – 2005-12-31: 42909000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -80027000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -78027000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -81620000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 5683000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	25380000	161674000 Derived	-136294000	-6292000 Derived	-130002000	-120271000 Derived	Source 2006-01-01 – 2006-12-31: 25380000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -136294000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -130002000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -113746000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 6525000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	38477000	189230000 Derived	-150753000	-2609000 Derived	-148144000	-93943000 Derived	Source 2007-01-01 – 2007-12-31: 38477000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -150753000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -148144000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -87501000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 6442000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	73989000	192588000 Derived	-118599000	-2358000 Derived	-116241000	-114447000 Derived	Source 2008-01-01 – 2008-12-31: 73989000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -118599000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -116241000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -109645000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 4802000 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	136972000	169027000 Derived	-32055000	10926000 Derived	-42981000	83687000 Derived	Source 2009-01-01 – 2009-12-31: 136972000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -32055000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -42981000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: 85488000 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 1801000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 137M 2009

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Revenue	32464247	Revenue: 32464247 Open source
20012001-12-31	Revenue	17828000	Revenue: 17828000 Open source
20022002-12-31	Revenue	52775000	Revenue: 52775000 Open source
20032003-12-31	Revenue	25957000	Revenue: 25957000 Open source
20042004-12-31	Revenue	35694000	Revenue: 35694000 Open source
20052005-12-31	Revenue	42909000	Revenue: 42909000 Open source
20062006-12-31	Revenue	25380000	Revenue: 25380000 Open source
20072007-12-31	Revenue	38477000	Revenue: 38477000 Open source
20082008-12-31	Revenue	73989000	Revenue: 73989000 Open source
20092009-12-31	Revenue	136972000	Revenue: 136972000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

85.1% 2009

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Year over year	-53.4%	Revenue: 32464247 Open source Revenue: 69675309 Open source
20012001-12-31	Year over year	-45.1%	Revenue: 17828000 Open source Revenue: 32464247 Open source
20022002-12-31	Year over year	196%	Revenue: 52775000 Open source Revenue: 17828000 Open source
20032003-12-31	Year over year	-50.8%	Revenue: 25957000 Open source Revenue: 52775000 Open source
20042004-12-31	Year over year	37.5%	Revenue: 35694000 Open source Revenue: 25957000 Open source
20052005-12-31	Year over year	20.2%	Revenue: 42909000 Open source Revenue: 35694000 Open source
20062006-12-31	Year over year	-40.9%	Revenue: 25380000 Open source Revenue: 42909000 Open source
20072007-12-31	Year over year	51.6%	Revenue: 38477000 Open source Revenue: 25380000 Open source
20082008-12-31	Year over year	92.3%	Revenue: 73989000 Open source Revenue: 38477000 Open source
20092009-12-31	Year over year	85.1%	Revenue: 136972000 Open source Revenue: 73989000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -23.4% 2009

Net margin -31.4% 2009

Free cash flow margin 61.1% 2009

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Operating margin	-89.1%	Operating Income: -28941627 Open source Revenue: 32464247 Open source
20012001-12-31	Operating margin	-248%	Operating Income: -44206000 Open source Revenue: 17828000 Open source
20022002-12-31	Operating margin	-69.4%	Operating Income: -36606000 Open source Revenue: 52775000 Open source
20032003-12-31	Operating margin	-232.7%	Operating Income: -60404000 Open source Revenue: 25957000 Open source
20042004-12-31	Operating margin	-243.4%	Operating Income: -86895000 Open source Revenue: 35694000 Open source
20052005-12-31	Operating margin	-186.5%	Operating Income: -80027000 Open source Revenue: 42909000 Open source
20062006-12-31	Operating margin	-537%	Operating Income: -136294000 Open source Revenue: 25380000 Open source
20072007-12-31	Operating margin	-391.8%	Operating Income: -150753000 Open source Revenue: 38477000 Open source
20082008-12-31	Operating margin	-160.3%	Operating Income: -118599000 Open source Revenue: 73989000 Open source
20092009-12-31	Operating margin	-23.4%	Operating Income: -32055000 Open source Revenue: 136972000 Open source
20002000-12-31	Net margin	-93.6%	Net Income: -30377060 Open source Revenue: 32464247 Open source
20012001-12-31	Net margin	-206.9%	Net Income: -36879000 Open source Revenue: 17828000 Open source
20022002-12-31	Net margin	-57.5%	Net Income: -30343000 Open source Revenue: 52775000 Open source
20032003-12-31	Net margin	-229.5%	Net Income: -59571000 Open source Revenue: 25957000 Open source
20042004-12-31	Net margin	-248.7%	Net Income: -88756000 Open source Revenue: 35694000 Open source
20052005-12-31	Net margin	-181.8%	Net Income: -78027000 Open source Revenue: 42909000 Open source
20062006-12-31	Net margin	-512.2%	Net Income: -130002000 Open source Revenue: 25380000 Open source
20072007-12-31	Net margin	-385%	Net Income: -148144000 Open source Revenue: 38477000 Open source
20082008-12-31	Net margin	-157.1%	Net Income: -116241000 Open source Revenue: 73989000 Open source
20092009-12-31	Net margin	-31.4%	Net Income: -42981000 Open source Revenue: 136972000 Open source
20002000-12-31	Free cash flow margin	-134.3%	Revenue: 32464247 Open source Operating Cash Flow: -37990447 Open source Capital Expenditure: 5617038 Open source
20012001-12-31	Free cash flow margin	-152.1%	Revenue: 17828000 Open source Operating Cash Flow: -18940000 Open source Capital Expenditure: 8181000 Open source
20022002-12-31	Free cash flow margin	-40.4%	Revenue: 52775000 Open source Operating Cash Flow: -11377000 Open source Capital Expenditure: 9943000 Open source
20032003-12-31	Free cash flow margin	-240.2%	Revenue: 25957000 Open source Operating Cash Flow: -49794000 Open source Capital Expenditure: 12562000 Open source
20042004-12-31	Free cash flow margin	-137.1%	Revenue: 35694000 Open source Operating Cash Flow: -31951000 Open source Capital Expenditure: 16969000 Open source
20052005-12-31	Free cash flow margin	-203.5%	Revenue: 42909000 Open source Operating Cash Flow: -81620000 Open source Capital Expenditure: 5683000 Open source
20062006-12-31	Free cash flow margin	-473.9%	Revenue: 25380000 Open source Operating Cash Flow: -113746000 Open source Capital Expenditure: 6525000 Open source
20072007-12-31	Free cash flow margin	-244.2%	Revenue: 38477000 Open source Operating Cash Flow: -87501000 Open source Capital Expenditure: 6442000 Open source
20082008-12-31	Free cash flow margin	-154.7%	Revenue: 73989000 Open source Operating Cash Flow: -109645000 Open source Capital Expenditure: 4802000 Open source
20092009-12-31	Free cash flow margin	61.1%	Revenue: 136972000 Open source Operating Cash Flow: 85488000 Open source Capital Expenditure: 1801000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 85.5M 2009

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Operating cash flow	-37990447	Operating Cash Flow: -37990447 Open source
20012001-12-31	Operating cash flow	-18940000	Operating Cash Flow: -18940000 Open source
20022002-12-31	Operating cash flow	-11377000	Operating Cash Flow: -11377000 Open source
20032003-12-31	Operating cash flow	-49794000	Operating Cash Flow: -49794000 Open source
20042004-12-31	Operating cash flow	-31951000	Operating Cash Flow: -31951000 Open source
20052005-12-31	Operating cash flow	-81620000	Operating Cash Flow: -81620000 Open source
20062006-12-31	Operating cash flow	-113746000	Operating Cash Flow: -113746000 Open source
20072007-12-31	Operating cash flow	-87501000	Operating Cash Flow: -87501000 Open source
20082008-12-31	Operating cash flow	-109645000	Operating Cash Flow: -109645000 Open source
20092009-12-31	Operating cash flow	85488000	Operating Cash Flow: 85488000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 83.7M 2009

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Free cash flow	-43607485	Operating Cash Flow: -37990447 Open source Capital Expenditure: 5617038 Open source
20012001-12-31	Free cash flow	-27121000	Operating Cash Flow: -18940000 Open source Capital Expenditure: 8181000 Open source
20022002-12-31	Free cash flow	-21320000	Operating Cash Flow: -11377000 Open source Capital Expenditure: 9943000 Open source
20032003-12-31	Free cash flow	-62356000	Operating Cash Flow: -49794000 Open source Capital Expenditure: 12562000 Open source
20042004-12-31	Free cash flow	-48920000	Operating Cash Flow: -31951000 Open source Capital Expenditure: 16969000 Open source
20052005-12-31	Free cash flow	-87303000	Operating Cash Flow: -81620000 Open source Capital Expenditure: 5683000 Open source
20062006-12-31	Free cash flow	-120271000	Operating Cash Flow: -113746000 Open source Capital Expenditure: 6525000 Open source
20072007-12-31	Free cash flow	-93943000	Operating Cash Flow: -87501000 Open source Capital Expenditure: 6442000 Open source
20082008-12-31	Free cash flow	-114447000	Operating Cash Flow: -109645000 Open source Capital Expenditure: 4802000 Open source
20092009-12-31	Free cash flow	83687000	Operating Cash Flow: 85488000 Open source Capital Expenditure: 1801000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

11.8% 2001

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Liabilities / assets	7%	Total Liabilities: 15975998 Open source Total Assets: 228636941 Open source
20012001-12-31	Liabilities / assets	11.8%	Total Liabilities: 24296061 Open source Total Assets: 205434564 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 347934000 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 375909000 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 412184000 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 453353000 Open source
2006-12-31	Liabilities / assets	Not reported	Total Assets: 347004000 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 263081000 Open source
2008-12-31	Liabilities / assets	Not reported	Total Assets: 210046000 Open source
2009-12-31	Liabilities / assets	Not reported	Total Assets: 319296000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.79× 2009

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Current assets / current liabilities	13.94×	Current Assets: 179088479 Open source Current Liabilities: 12843630 Open source
20012001-12-31	Current assets / current liabilities	10.28×	Current Assets: 153423948 Open source Current Liabilities: 14931123 Open source
20022002-12-31	Current assets / current liabilities	15.2×	Current Assets: 291407000 Open source Current Liabilities: 19171000 Open source
20032003-12-31	Current assets / current liabilities	14.6×	Current Assets: 308544000 Open source Current Liabilities: 21131000 Open source
20042004-12-31	Current assets / current liabilities	9×	Current Assets: 334510000 Open source Current Liabilities: 37149000 Open source
20052005-12-31	Current assets / current liabilities	11.82×	Current Assets: 375195000 Open source Current Liabilities: 31736000 Open source
20062006-12-31	Current assets / current liabilities	9.56×	Current Assets: 267390000 Open source Current Liabilities: 27958000 Open source
20072007-12-31	Current assets / current liabilities	2.86×	Current Assets: 182782000 Open source Current Liabilities: 63960000 Open source
20082008-12-31	Current assets / current liabilities	2.33×	Current Assets: 132956000 Open source Current Liabilities: 56968000 Open source
20092009-12-31	Current assets / current liabilities	1.79×	Current Assets: 249869000 Open source Current Liabilities: 139816000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2000 2000-01-01 – 2000-12-31	−USD 30.38 million Exact value Exact value: -30377060 USD 2000-01-01 – 2000-12-31: -30377060 USD Inspect Net Income Open source Share or cite Citation for Net Income · ZYMOGENETICS INC · 2000-12-31 ZYMOGENETICS INC (edgar:1129425) Net Income: -30377060 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -30377060 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-03-021157.txt#3305 The citation records this snapshot. The page link may show a newer release later.	−USD 37.99 million Exact value Exact value: -37990447 USD 2000-01-01 – 2000-12-31: -37990447 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ZYMOGENETICS INC · 2000-12-31 ZYMOGENETICS INC (edgar:1129425) Operating Cash Flow: -37990447 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -37990447 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-03-021157.txt#3571 The citation records this snapshot. The page link may show a newer release later.	USD 5.62 million Exact value Exact value: 5617038 USD 2000-01-01 – 2000-12-31: 5617038 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ZYMOGENETICS INC · 2000-12-31 ZYMOGENETICS INC (edgar:1129425) Capital Expenditure: 5617038 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5617038 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-03-021157.txt#3613 The citation records this snapshot. The page link may show a newer release later.	−USD 43.61 million Calculation and evidence -37990447 − 5617038 USD Exact free cash flow: -43607485 USD 2000-01-01 – 2000-12-31: -37990447 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 5617038 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ZYMOGENETICS INC · 2000-12-31 ZYMOGENETICS INC (edgar:1129425) Free cash flow: -43607485 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -37990447 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-03-021157.txt#3571 Input fundies:CapitalExpenditure: 5617038 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-03-021157.txt#3613 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 36.88 million Exact value Exact value: -36879000 USD 2001-01-01 – 2001-12-31: -36879000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ZYMOGENETICS INC · 2001-12-31 ZYMOGENETICS INC (edgar:1129425) Net Income: -36879000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -36879000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-04-052427.txt#6720 The citation records this snapshot. The page link may show a newer release later.	−USD 18.94 million Exact value Exact value: -18940000 USD 2001-01-01 – 2001-12-31: -18940000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ZYMOGENETICS INC · 2001-12-31 ZYMOGENETICS INC (edgar:1129425) Operating Cash Flow: -18940000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18940000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-04-052427.txt#6958 The citation records this snapshot. The page link may show a newer release later.	USD 8.18 million Exact value Exact value: 8181000 USD 2001-01-01 – 2001-12-31: 8181000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ZYMOGENETICS INC · 2001-12-31 ZYMOGENETICS INC (edgar:1129425) Capital Expenditure: 8181000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8181000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-04-052427.txt#7005 The citation records this snapshot. The page link may show a newer release later.	−USD 27.12 million Calculation and evidence -18940000 − 8181000 USD Exact free cash flow: -27121000 USD 2001-01-01 – 2001-12-31: -18940000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 8181000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ZYMOGENETICS INC · 2001-12-31 ZYMOGENETICS INC (edgar:1129425) Free cash flow: -27121000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18940000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-04-052427.txt#6958 Input fundies:CapitalExpenditure: 8181000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-04-052427.txt#7005 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 30.34 million Exact value Exact value: -30343000 USD 2002-01-01 – 2002-12-31: -30343000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ZYMOGENETICS INC · 2002-12-31 ZYMOGENETICS INC (edgar:1129425) Net Income: -30343000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -30343000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-05-049565.txt#7058 The citation records this snapshot. The page link may show a newer release later.	−USD 11.38 million Exact value Exact value: -11377000 USD 2002-01-01 – 2002-12-31: -11377000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ZYMOGENETICS INC · 2002-12-31 ZYMOGENETICS INC (edgar:1129425) Operating Cash Flow: -11377000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11377000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-05-049565.txt#7282 The citation records this snapshot. The page link may show a newer release later.	USD 9.94 million Exact value Exact value: 9943000 USD 2002-01-01 – 2002-12-31: 9943000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ZYMOGENETICS INC · 2002-12-31 ZYMOGENETICS INC (edgar:1129425) Capital Expenditure: 9943000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9943000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-05-049565.txt#7329 The citation records this snapshot. The page link may show a newer release later.	−USD 21.32 million Calculation and evidence -11377000 − 9943000 USD Exact free cash flow: -21320000 USD 2002-01-01 – 2002-12-31: -11377000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 9943000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ZYMOGENETICS INC · 2002-12-31 ZYMOGENETICS INC (edgar:1129425) Free cash flow: -21320000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11377000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-05-049565.txt#7282 Input fundies:CapitalExpenditure: 9943000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-05-049565.txt#7329 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 59.57 million Exact value Exact value: -59571000 USD 2003-01-01 – 2003-12-31: -59571000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ZYMOGENETICS INC · 2003-12-31 ZYMOGENETICS INC (edgar:1129425) Net Income: -59571000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -59571000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-06-053764.txt#6883 The citation records this snapshot. The page link may show a newer release later.	−USD 49.79 million Exact value Exact value: -49794000 USD 2003-01-01 – 2003-12-31: -49794000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ZYMOGENETICS INC · 2003-12-31 ZYMOGENETICS INC (edgar:1129425) Operating Cash Flow: -49794000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -49794000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-06-053764.txt#7135 The citation records this snapshot. The page link may show a newer release later.	USD 12.56 million Exact value Exact value: 12562000 USD 2003-01-01 – 2003-12-31: 12562000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ZYMOGENETICS INC · 2003-12-31 ZYMOGENETICS INC (edgar:1129425) Capital Expenditure: 12562000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12562000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-06-053764.txt#7182 The citation records this snapshot. The page link may show a newer release later.	−USD 62.36 million Calculation and evidence -49794000 − 12562000 USD Exact free cash flow: -62356000 USD 2003-01-01 – 2003-12-31: -49794000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 12562000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ZYMOGENETICS INC · 2003-12-31 ZYMOGENETICS INC (edgar:1129425) Free cash flow: -62356000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -49794000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-06-053764.txt#7135 Input fundies:CapitalExpenditure: 12562000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-06-053764.txt#7182 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 88.76 million Exact value Exact value: -88756000 USD 2004-01-01 – 2004-12-31: -88756000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ZYMOGENETICS INC · 2004-12-31 ZYMOGENETICS INC (edgar:1129425) Net Income: -88756000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -88756000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-07-043847.txt#6935 The citation records this snapshot. The page link may show a newer release later.	−USD 31.95 million Exact value Exact value: -31951000 USD 2004-01-01 – 2004-12-31: -31951000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ZYMOGENETICS INC · 2004-12-31 ZYMOGENETICS INC (edgar:1129425) Operating Cash Flow: -31951000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31951000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-07-043847.txt#7187 The citation records this snapshot. The page link may show a newer release later.	USD 16.97 million Exact value Exact value: 16969000 USD 2004-01-01 – 2004-12-31: 16969000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ZYMOGENETICS INC · 2004-12-31 ZYMOGENETICS INC (edgar:1129425) Capital Expenditure: 16969000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16969000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-07-043847.txt#7234 The citation records this snapshot. The page link may show a newer release later.	−USD 48.92 million Calculation and evidence -31951000 − 16969000 USD Exact free cash flow: -48920000 USD 2004-01-01 – 2004-12-31: -31951000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 16969000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ZYMOGENETICS INC · 2004-12-31 ZYMOGENETICS INC (edgar:1129425) Free cash flow: -48920000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31951000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-07-043847.txt#7187 Input fundies:CapitalExpenditure: 16969000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-07-043847.txt#7234 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 78.03 million Exact value Exact value: -78027000 USD 2005-01-01 – 2005-12-31: -78027000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ZYMOGENETICS INC · 2005-12-31 ZYMOGENETICS INC (edgar:1129425) Net Income: -78027000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -78027000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-08-043300.txt#7149 The citation records this snapshot. The page link may show a newer release later.	−USD 81.62 million Exact value Exact value: -81620000 USD 2005-01-01 – 2005-12-31: -81620000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ZYMOGENETICS INC · 2005-12-31 ZYMOGENETICS INC (edgar:1129425) Operating Cash Flow: -81620000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -81620000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-08-043300.txt#7387 The citation records this snapshot. The page link may show a newer release later.	USD 5.68 million Exact value Exact value: 5683000 USD 2005-01-01 – 2005-12-31: 5683000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ZYMOGENETICS INC · 2005-12-31 ZYMOGENETICS INC (edgar:1129425) Capital Expenditure: 5683000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5683000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-08-043300.txt#7434 The citation records this snapshot. The page link may show a newer release later.	−USD 87.3 million Calculation and evidence -81620000 − 5683000 USD Exact free cash flow: -87303000 USD 2005-01-01 – 2005-12-31: -81620000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 5683000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ZYMOGENETICS INC · 2005-12-31 ZYMOGENETICS INC (edgar:1129425) Free cash flow: -87303000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -81620000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-08-043300.txt#7387 Input fundies:CapitalExpenditure: 5683000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-08-043300.txt#7434 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 130 million Exact value Exact value: -130002000 USD 2006-01-01 – 2006-12-31: -130002000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ZYMOGENETICS INC · 2006-12-31 ZYMOGENETICS INC (edgar:1129425) Net Income: -130002000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -130002000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-09-047599.txt#6369 The citation records this snapshot. The page link may show a newer release later.	−USD 113.75 million Exact value Exact value: -113746000 USD 2006-01-01 – 2006-12-31: -113746000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ZYMOGENETICS INC · 2006-12-31 ZYMOGENETICS INC (edgar:1129425) Operating Cash Flow: -113746000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -113746000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-09-047599.txt#6663 The citation records this snapshot. The page link may show a newer release later.	USD 6.53 million Exact value Exact value: 6525000 USD 2006-01-01 – 2006-12-31: 6525000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ZYMOGENETICS INC · 2006-12-31 ZYMOGENETICS INC (edgar:1129425) Capital Expenditure: 6525000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6525000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-09-047599.txt#6705 The citation records this snapshot. The page link may show a newer release later.	−USD 120.27 million Calculation and evidence -113746000 − 6525000 USD Exact free cash flow: -120271000 USD 2006-01-01 – 2006-12-31: -113746000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 6525000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ZYMOGENETICS INC · 2006-12-31 ZYMOGENETICS INC (edgar:1129425) Free cash flow: -120271000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -113746000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-09-047599.txt#6663 Input fundies:CapitalExpenditure: 6525000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-09-047599.txt#6705 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 148.14 million Exact value Exact value: -148144000 USD 2007-01-01 – 2007-12-31: -148144000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ZYMOGENETICS INC · 2007-12-31 ZYMOGENETICS INC (edgar:1129425) Net Income: -148144000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -148144000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6300 The citation records this snapshot. The page link may show a newer release later.	−USD 87.5 million Exact value Exact value: -87501000 USD 2007-01-01 – 2007-12-31: -87501000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ZYMOGENETICS INC · 2007-12-31 ZYMOGENETICS INC (edgar:1129425) Operating Cash Flow: -87501000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -87501000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6608 The citation records this snapshot. The page link may show a newer release later.	USD 6.44 million Exact value Exact value: 6442000 USD 2007-01-01 – 2007-12-31: 6442000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ZYMOGENETICS INC · 2007-12-31 ZYMOGENETICS INC (edgar:1129425) Capital Expenditure: 6442000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6442000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6650 The citation records this snapshot. The page link may show a newer release later.	−USD 93.94 million Calculation and evidence -87501000 − 6442000 USD Exact free cash flow: -93943000 USD 2007-01-01 – 2007-12-31: -87501000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 6442000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ZYMOGENETICS INC · 2007-12-31 ZYMOGENETICS INC (edgar:1129425) Free cash flow: -93943000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -87501000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6608 Input fundies:CapitalExpenditure: 6442000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6650 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 116.24 million Exact value Exact value: -116241000 USD 2008-01-01 – 2008-12-31: -116241000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ZYMOGENETICS INC · 2008-12-31 ZYMOGENETICS INC (edgar:1129425) Net Income: -116241000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -116241000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6300 The citation records this snapshot. The page link may show a newer release later.	−USD 109.65 million Exact value Exact value: -109645000 USD 2008-01-01 – 2008-12-31: -109645000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ZYMOGENETICS INC · 2008-12-31 ZYMOGENETICS INC (edgar:1129425) Operating Cash Flow: -109645000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -109645000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6608 The citation records this snapshot. The page link may show a newer release later.	USD 4.8 million Exact value Exact value: 4802000 USD 2008-01-01 – 2008-12-31: 4802000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ZYMOGENETICS INC · 2008-12-31 ZYMOGENETICS INC (edgar:1129425) Capital Expenditure: 4802000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4802000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6650 The citation records this snapshot. The page link may show a newer release later.	−USD 114.45 million Calculation and evidence -109645000 − 4802000 USD Exact free cash flow: -114447000 USD 2008-01-01 – 2008-12-31: -109645000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 4802000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ZYMOGENETICS INC · 2008-12-31 ZYMOGENETICS INC (edgar:1129425) Free cash flow: -114447000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -109645000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6608 Input fundies:CapitalExpenditure: 4802000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6650 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 42.98 million Exact value Exact value: -42981000 USD 2009-01-01 – 2009-12-31: -42981000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ZYMOGENETICS INC · 2009-12-31 ZYMOGENETICS INC (edgar:1129425) Net Income: -42981000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -42981000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6300 The citation records this snapshot. The page link may show a newer release later.	USD 85.49 million Exact value Exact value: 85488000 USD 2009-01-01 – 2009-12-31: 85488000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ZYMOGENETICS INC · 2009-12-31 ZYMOGENETICS INC (edgar:1129425) Operating Cash Flow: 85488000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 85488000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6608 The citation records this snapshot. The page link may show a newer release later.	USD 1.8 million Exact value Exact value: 1801000 USD 2009-01-01 – 2009-12-31: 1801000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ZYMOGENETICS INC · 2009-12-31 ZYMOGENETICS INC (edgar:1129425) Capital Expenditure: 1801000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1801000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6650 The citation records this snapshot. The page link may show a newer release later.	USD 83.69 million Calculation and evidence 85488000 − 1801000 USD Exact free cash flow: 83687000 USD 2009-01-01 – 2009-12-31: 85488000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 1801000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ZYMOGENETICS INC · 2009-12-31 ZYMOGENETICS INC (edgar:1129425) Free cash flow: 83687000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T17:51:27Z Snapshot: a2e3fb85c35a87811473d97b3340a15447316aa922d46e61271cd7275e95d4aa Dimensions: Consolidated View: https://fundies.io/companies/edgar/1129425?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 85488000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6608 Input fundies:CapitalExpenditure: 1801000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1129425/0001193125-10-043192.txt#6650 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

37 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001129425, 1129425, edgar:1129425

ZYMOGENETICS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2009 2009-01-01 – 2009-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation